Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other Accumulated Expenses: 2024

Historic Other Accumulated Expenses for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $2.7 million.

  • Kura Oncology's Other Accumulated Expenses rose 154.21% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 154.21%. This contributed to the annual value of $2.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Other Accumulated Expenses of $2.7 million as of FY2024.
  • In the past 5 years, Kura Oncology's Other Accumulated Expenses registered a high of $2.7 million during FY2024, and its lowest value of $2.7 million during FY2024.
  • Over the past 1 years, Kura Oncology's median Other Accumulated Expenses value was $2.7 million (recorded in 2024), while the average stood at $2.7 million.